3 Top Diabetes Biotechs to Buy Into Right Now Post author:Sam Post published:November 26, 2017 Post category:BioPharma Diabetes is huge problem for Americans. Source: BioSpace You Might Also Like Regeneron Keeps Science at the Center January 16, 2018 FDA Calls Omeros' Kidney Disorder Drug a Breakthrough June 12, 2017 Celgene Takes a $411M Hit From Discontinuation of Crohn's Disease Trials December 28, 2017
